We are live on
!
Find out more
HCM
Highbridge Capital Management Portfolio holdings
AUM
$3.09B
1-Year Est. Return
31.19%
This Fund
S&P 500
This Quarter
Est. Return
-11.59%
1 Year Est. Return
+31.19%
3 Year Est. Return
+54.53%
5 Year Est. Return
+78.37%
10 Year Est. Return
+191.39%
AUM
$6.48B
AUM Growth
-$1.46B
(-18%)
Cap. Flow
-$813M
Cap. Flow
% of AUM
-12.56%
Top 10 Holdings %
Top 10 Hldgs %
9.89%
Holding
2,087
New
729
Increased
336
Reduced
354
Closed
610
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CXRX
Concordia International Corp. Common Stock
CXRX
|
+$70M |
| 2 |
Oracle
ORCL
|
+$69.5M |
| 3 |
Exelon
EXC
|
+$68.4M |
| 4 |
Devon Energy
DVN
|
+$50.7M |
| 5 |
GoPro
GPRO
|
+$41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$65.3M |
| 2 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$53.8M |
| 3 |
Merck
MRK
|
+$52.6M |
| 4 |
American Electric Power
AEP
|
+$48.9M |
| 5 |
United Parcel Service
UPS
|
+$47M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.25% |
| 2 | Technology | 10.59% |
| 3 | Industrials | 6.69% |
| 4 | Consumer Discretionary | 6.67% |
| 5 | Financials | 5.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANCX
1226
DELISTED
Access National Corp
ANCX
| $274K | ﹤0.01% |
+13,476
| New | +$269K |
|
1227
CALL
Hormel Foods
HRL
$13.9B
| $272K | ﹤0.01% |
+8,600
| New | +$258K |
|
|
CSII
1228
PUT
DELISTED
Cardiovascular Systems, Inc.
CSII
| $271K | ﹤0.01% |
+17,100
| New | +$431K |
|
1229
Open Text
OTEX
$6.34B
| $269K | ﹤0.01% |
12,000
+800
| +7% | +$17.3K |
|
1230
Bausch Health
BHC
$2.62B
| $268K | ﹤0.01% |
+1,500
| New | +$350K |
|
1231
CALL
Union Pacific
UNP
$173B
| $267K | ﹤0.01% |
3,000
-3,800
| -56% | -$347K |
|
|
SCMP
1232
CALL
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $267K | ﹤0.01% |
+13,400
| New | +$307K |
|
|
LQ
1233
PUT
DELISTED
La Quinta Holdings Inc.
LQ
| $266K | ﹤0.01% |
+16,900
| New | +$340K |
|
|
ECYT
1234
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $265K | ﹤0.01% |
+57,783
| New | +$302K |
|
|
RP
1235
DELISTED
RealPage, Inc.
RP
| $264K | ﹤0.01% |
15,915
-25,041
| -61% | -$465K |
|
1236
RTX Corp
RTX
$292B
| $262K | ﹤0.01% |
+4,684
| New | +$288K |
|
1237
Atara Biotherapeutics
ATRA
$77M
| $261K | ﹤0.01% |
+331
| New | +$404K |
|
1238
PUT
Kadant
KAI
$3.83B
| $261K | ﹤0.01% |
+6,700
| New | +$295K |
|
1239
PUT
Kennametal
KMT
$2.66B
| $261K | ﹤0.01% |
+10,500
| New | +$314K |
|
1240
Titan International
TWI
$466M
| $260K | ﹤0.01% |
39,281
-29,752
| -43% | -$259K |
|
1241
FormFactor
FORM
$8.48B
| $259K | ﹤0.01% |
+38,343
| New | +$268K |
|
1242
CALL
Procter & Gamble
PG
$338B
| $259K | ﹤0.01% |
3,600
-2,200
| -38% | -$165K |
|
1243
PUT
Sensata Technologies
ST
$6.81B
| $258K | ﹤0.01% |
+5,800
| New | +$280K |
|
1244
CALL
Yelp
YELP
$1.47B
| $258K | ﹤0.01% |
+11,900
| New | +$330K |
|
|
CZR
1245
DELISTED
Caesars Entertainment Corporation
CZR
| $258K | ﹤0.01% |
+43,775
| New | +$323K |
|
|
KITE
1246
CALL
DELISTED
Kite Pharma, Inc.
KITE
| $256K | ﹤0.01% |
4,600
-19,700
| -81% | -$1.24M |
|
|
SGMO
1247
PUT
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $255K | ﹤0.01% |
+45,200
| New | +$373K |
|
1248
PUT
Ford
F
$57.5B
| $254K | ﹤0.01% |
18,800
-16,900
| -47% | -$241K |
|
1249
Kirby Corp
KEX
$6.98B
| $254K | ﹤0.01% |
+4,100
| New | +$290K |
|
1250
CALL
Tapestry
TPR
$31.4B
| $254K | ﹤0.01% |
+8,800
| New | +$272K |
|
Similar funds
DCM
CAM
VBA
MRCP
ECP
TCG
PC
CCI
Highbridge Capital Management's Q3 2015 Portfolio in Review
As of Q3 2015, Highbridge Capital Management held 2,087 positions worth $6.48B, down 18% from $7.94B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
Highbridge Capital Management withdrew a net $813M in Q3 2015, closing 610 positions and reducing 354 holdings. Its most notable exit was DIRECTV COM STK (DE), an estimated $53.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 13% a quarter earlier, followed by Technology and Industrials.
Against the trend, Highbridge Capital Management opened a new position in Concordia International Corp. Common Stock worth $40.2M.
- Highbridge Capital Management's largest Q3 2015 buy was Concordia International Corp. Common Stock: 945,100 shares worth $40.2M.
- Highbridge Capital Management added most to Exelon in Q3 2015, an estimated $68.4M increase.
- Highbridge Capital Management's biggest Q3 2015 reduction was Johnson & Johnson, cutting an estimated $65.3M.
- Highbridge Capital Management fully exited DIRECTV COM STK (DE) in Q3 2015, selling an estimated $53.8M.
- Highbridge Capital Management's ten largest holdings make up 9.9% of its $6.48B portfolio in Q3 2015.
- Highbridge Capital Management opened 729 new positions and closed 610 in Q3 2015.
- Highbridge Capital Management's portfolio value fell 18% quarter-over-quarter to $6.48B.
Based on Highbridge Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.